Bayer AG (BAYGn.DE)

BAYGn.DE on Xetra

139.15EUR
27 Mar 2015
Change (% chg)

€0.35 (+0.25%)
Prev Close
€138.80
Open
€139.90
Day's High
€140.30
Day's Low
€137.90
Volume
1,880,892
Avg. Vol
2,278,743
52-wk High
€145.85
52-wk Low
€91.51

BAYGn.DE

Chart for BAYGn.DE

About

Bayer AG is a German holding company active in the field of health care, nutrition and high-tech materials. It has three subgroups: HealthCare, involved in the research, development and production of health products for people and animals, CropScience, engaged in the crop protection and non-agricultural pest control, and... (more)

Overall

Beta: 0.92
Market Cap(Mil.): €115,069.80
Shares Outstanding(Mil.): 826.95
Dividend: 2.25
Yield (%): 1.62

Financials

  BAYGn.DE Industry Sector
P/E (TTM): 33.59 40.31 40.78
EPS (TTM): 4.14 -- --
ROI: 7.50 16.86 16.19
ROE: 16.78 17.40 17.04
Search Stocks

BRIEF-Bayer receives approval of Gadovist injection in Japan

* Receives approval for Gadovist (gadobutrol) injection in Japan Further company coverage:

26 Mar 2015

Bayer weighing options for consumer garden products

FRANKFURT - Germany's Bayer said it was considering strategic options for its home and garden consumer products business, maker of Baby Bio plant feed, as its crop protection arm focuses on professional customers.

20 Mar 2015

Bayer weighing options for consumer garden products

FRANKFURT - Germany's Bayer said it was considering strategic options for its home and garden consumer products business, maker of Baby Bio plant feed, as its crop protection arm focuses on professional customers.

20 Mar 2015

UPDATE 1-Bayer weighing options for consumer garden products

* Bayer preparing sale of consumer home and garden unit-sources

20 Mar 2015

Bayer weighing options for consumer house and garden products

FRANKFURT, March 20 - Germany's largest drugmaker Bayer said it was considering strategic options for the consumer products part of its Environmental Science business, which makes about 220 million euros ($236 million) in sales from pesticides, pest control products and fertilisers.

20 Mar 2015

Whistleblower who won now fighting to regain job at Bayer

- A former Bayer salesman from Arkansas who successfully blew the whistle in a health fraud case has returned to court to try and get his job back two years after a judge ordered the pharmaceutical company to reinstate him.

18 Mar 2015

Judge lets Bayer vitamin suit proceed, but axes heart, immunity claims

- Plaintiffs suing Bayer AG over its One-A-Day vitamins can proceed with claims that the products falsely stated it could boost physical energy, although a judge dismissed similar claims that the vitamins could improve heart health and immunity.

11 Mar 2015

Bayer aims to boost drugs sales, margins over next three years

FRANKFURT - Bayer aims to increase sales of its main healthcare division by an annual 6 percent until 2017, with growth prospects for new drugs such as stroke prevention pill Xarelto boosting shares in Germany's largest drugmaker.

11 Mar 2015

UPDATE 2-Bayer aims to boost drugs sales, margins over next 3 years

* Bayer says healthcare unit to grow 6 pct per year until 2017

11 Mar 2015

BRIEF-Bayer to float MaterialScience by mid-2016 at latest

* Says for CropScience as a whole, the aim is to achieve above-market growth and raise sales to more than eur 11 billion in 2017 (2014: eur 9.5 billion),

11 Mar 2015

Earnings vs. Estimates

Search Stocks